Lista de obras - Pascual Marco - Dominio Público Uruguay

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

artículo científico publicado en 2002

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

artículo científico publicado en 2015

Annexin V levels in survivors of early myocardial infarction

artículo científico publicado en 2002

Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation

scientific article published on 01 July 2000

Association between the Thr325Ile and Ala147Thr polymorphisms of the TAFI gene and the risk of venous thromboembolic disease

artículo científico publicado en 2007

Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study

artículo científico publicado en 2013

Dealing with refractoriness in obstetric primary antiphospholipid syndrome--often not a matter of success

artículo científico publicado en 2014

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

artículo científico publicado en 2012

Diurnal variation in the intensity of anticoagulation in atrial fibrillation.

artículo científico publicado en 2002

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

artículo científico publicado en 2002

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

artículo científico publicado en 2014

Fatal varicella with primary fibrinolysis in a renal transplant recipient

artículo científico publicado en 1999

Hypofibrinolysis in atrial fibrillation

scientific article published on 01 December 1998

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

artículo científico publicado en 2019

Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

artículo científico publicado en 2015

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

artículo científico publicado en 2012

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

artículo científico publicado en 2003

Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients

scientific article published on 01 April 2019

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

artículo científico publicado en 2003

Levels of tissue factor pathway inhibitor in lupus patients correlate with lupus activity and endothelial damage markers.

artículo científico publicado en 2002

Management of bleeding disorders: basic science.

artículo científico publicado en 2012

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

artículo científico publicado en 2012

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm

artículo científico publicado en 2015

More on thromboprophylaxis: electronic alerts in hospitalized patients at risk of venous thromboembolism

artículo científico publicado en 2008

Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document)

artículo científico publicado en 2015

Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document).

artículo científico

Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

scientific article published on 14 November 2018

Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.

artículo científico publicado en 2004

New clinical perspectives in the management of oral direct anticoagulant agents

artículo científico publicado en 2013

New oral anticoagulants: molecular characteristics, mechanisms of action, pharmacokinetics and pharmacodynamics

artículo científico publicado en 2008

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

artículo científico publicado en 2012

Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers

artículo científico publicado en 2008

Premature myocardial infarction: clinical profile and angiographic findings

scientific article published on 25 April 2007

Primary antiphospholipid syndrome and osteonecrosis

scientific article published on 01 September 1991

Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis

artículo científico publicado en 2010

Prognostic value of fibrinolytic tests for hospital outcome in patients with acute upper gastrointestinal hemorrhage

scientific article published on 01 April 2001

Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples

scientific article published on 01 June 2002

Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation

scientific article published on 01 October 1999

Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels

artículo científico publicado en 1996

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

artículo científico publicado en 2018

Semi-automated evaluation tool for retinal vasculopathy.

artículo científico publicado en 2009

The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease

artículo científico publicado en 2016

The fibrinolytic system in patients with dilated myocardiopathy

artículo científico publicado en 1996

The national registry of haemophilia A and B in Spain: results from a census of patients.

artículo científico publicado en 2009

The prognostic value of biomarkers after a premature myocardial infarction

artículo científico publicado en 2009

The role of antiphospholipid antibodies in lupus nephropathy

artículo científico publicado en 1995

The role of tissue plasminogen activator on the progression of the coronary disease

artículo científico publicado en 2002

Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD)

scientific article published on 01 March 2006

Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists

artículo científico publicado en 2009

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

artículo científico publicado en 2020

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

scientific article published on 25 October 2018

Upshaw-Schulman Syndrome: Novel homozygous missense mutation

artículo científico publicado en 2017

Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.

artículo científico publicado en 2007

[Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy]

artículo científico publicado en 1995

[Genetic thrombophilia and cerebral venous thrombosis]

scientific article published on 01 May 2007

[Hematoma of the anterior rectus abdominis muscle as the first manifestation of lymphoproliferative disease after renal transplantation]

artículo científico publicado en 2000

[Heparin-induced thrombocytopenia with thrombosis and cardiovascular surgery]

artículo científico publicado en 2005

[Prospective study of the risk factors for the development of post-thrombotic syndrome after proximal deep venous thrombosis]

scientific article published on 01 June 2005

[Visceral leishmaniasis associated with disseminated intravascular coagulation. Report of 2 cases]

artículo científico publicado en 1993

Lista de obras de Pascual Marco

A common polymorphism in the annexin V Kozak sequence (-1C>T) increases translation efficiency and plasma levels of annexin V, and decreases the risk of myocardial infarction in young patients

Adherence to prophylaxis and quality of life in children and adolescents with severe haemophilia A.

Annexin V levels in survivors of early myocardial infarction

Anticoagulant therapy modifies fibrinolytic dysfunction in chronic atrial fibrillation

Association between the Thr325Ile and Ala147Thr polymorphisms of the TAFI gene and the risk of venous thromboembolic disease

Bemiparin versus unfractionated heparin as bridging therapy in the perioperative management of patients on vitamin K antagonists: the BERTA study

Dealing with refractoriness in obstetric primary antiphospholipid syndrome--often not a matter of success

Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Diurnal variation in the intensity of anticoagulation in atrial fibrillation.

Do protein Z levels influence the prothrombotic state in atrial fibrillation?

Effects of Body Mass Index on the Lipid Profile and Biomarkers of Inflammation and a Fibrinolytic and Prothrombotic State

Fatal varicella with primary fibrinolysis in a renal transplant recipient

Hypofibrinolysis in atrial fibrillation

Identification of 58 Mutations (26 Novel) in 94 of 109 Symptomatic Spanish Probands with Protein C Deficiency

Identification of new markers of recurrence in patients with unprovoked deep vein thrombosis by gene expression profiling: the retro study

Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2).

Interleukin-6, endothelial activation and thrombogenesis in chronic atrial fibrillation

Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients

Is thrombogenesis in atrial fibrillation related to matrix metalloproteinase-1 and its inhibitor, TIMP-1?

Levels of tissue factor pathway inhibitor in lupus patients correlate with lupus activity and endothelial damage markers.

Management of bleeding disorders: basic science.

Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry

Molecular and clinical profile of von Willebrand disease in Spain (PCM-EVW-ES): Proposal for a new diagnostic paradigm

More on thromboprophylaxis: electronic alerts in hospitalized patients at risk of venous thromboembolism

Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document)

Multidisciplinary consensus document on the management of massive haemorrhage (HEMOMAS document).

Multiparameter Flow Cytometry Identification of Neoplastic Subclones: A New Biomarker in Monoclonal Gammopathy of Undetermined Significance and Multiple Myeloma

Mutations in the shutter region of antithrombin result in formation of disulfide-linked dimers and severe venous thrombosis.

New clinical perspectives in the management of oral direct anticoagulant agents

New oral anticoagulants: molecular characteristics, mechanisms of action, pharmacokinetics and pharmacodynamics

Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry

Premature coronary artery disease in young (age <45) subjects: interactions of lipid profile, thrombophilic and haemostatic markers

Premature myocardial infarction: clinical profile and angiographic findings

Primary antiphospholipid syndrome and osteonecrosis

Prognosis value of thrombin activatable fibrinolysis inhibitor concentration and C1040T polymorphism in acute myocardial infarction treated with fibrinolysis

Prognostic value of fibrinolytic tests for hospital outcome in patients with acute upper gastrointestinal hemorrhage

Prothrombin fragment F1+2 and von Willebrand factor levels and left ventricular systolic function. Peripheral versus intracardiac blood samples

Prothrombotic state and elevated levels of plasminogen activator inhibitor-1 in mitral stenosis with and without atrial fibrillation

Quantification of circulating activated protein C in human plasma by immunoassays--enzyme levels are proportional to total protein C levels

Role of multimeric analysis of von Willebrand factor (VWF) in von Willebrand disease (VWD) diagnosis: Lessons from the PCM-EVW-ES Spanish project.

Semi-automated evaluation tool for retinal vasculopathy.

The Unravelling of the Genetic Architecture of Plasminogen Deficiency and its Relation to Thrombotic Disease

The fibrinolytic system in patients with dilated myocardiopathy

The national registry of haemophilia A and B in Spain: results from a census of patients.

The prognostic value of biomarkers after a premature myocardial infarction

The role of antiphospholipid antibodies in lupus nephropathy

The role of tissue plasminogen activator on the progression of the coronary disease

Thrombin activatable fibrinolysis inhibitor (TAFI) polymorphisms and plasma TAFI levels measured with an ELISA insensitive to isoforms in patients with venous thromboembolic disease (VTD)

Thrombin generation test in patients under anticoagulant therapy with vitamin K antagonists

Unraveling the Influence of Common von Willebrand factor variants on von Willebrand Disease Phenotype: An Exploratory Study on the Molecular and Clinical Profile of von Willebrand Disease in Spain Cohort

Unraveling the effect of silent, intronic and missense mutations on VWF splicing: contribution of next generation sequencing in the study of mRNA

Upshaw-Schulman Syndrome: Novel homozygous missense mutation

Von Willebrand factor in high-purity factor VIII complex concentrates: chaperone protein or key to therapies? A meeting report.

[Antiphospholipid antibodies in women with habitual abortions. Treatment with prednisone and acetylsalicylic acid during pregnancy]

[Genetic thrombophilia and cerebral venous thrombosis]

[Hematoma of the anterior rectus abdominis muscle as the first manifestation of lymphoproliferative disease after renal transplantation]

[Heparin-induced thrombocytopenia with thrombosis and cardiovascular surgery]

[Prospective study of the risk factors for the development of post-thrombotic syndrome after proximal deep venous thrombosis]

[Visceral leishmaniasis associated with disseminated intravascular coagulation. Report of 2 cases]